J-l L. Van Laethem
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Journal: ESMO open
Published: November 16, 2021
What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
Journal: Annals of surgical oncology
Published: September 25, 2020
Pathological complete response after neoadjuvant immunotherapy for a patient with microsatellite instability locally advanced rectal cancer: should we adapt our standard management for these patients?
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 06, 2020
Aquaporins Involvement in Pancreas Physiology and in Pancreatic Diseases.
Journal: International journal of molecular sciences
Published: September 19, 2019
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 05, 2019
Induction chemotherapy in borderline (non-)resectable pancreatic cancer: a unique window of opportunity for understanding pancreatic cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 25, 2018
Assessment of response to chemotherapy in pancreatic ductal adenocarcinoma: Comparison between diffusion-weighted MR quantitative parameters and RECIST.
Journal: European journal of radiology
Published: September 04, 2017
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
Journal: Targeted oncology
Published: December 16, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 22, 2016
The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 29, 2016
CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA
Journal: Revue medicale de Liege
Published: January 08, 2016
Last Updated: 09/26/2026